X hits on this document





3 / 7

OTC Market-Due to the rising population and greater tendency for consumers to self-medicate the Mexican OTC market share is steadily rising. The concept of wellness is beginning to develop in Mexico, and is expected to become an increasingly important factor in creating demand for OTC healthcare products. As such, consumer’s awareness of preventative health measures, nutrition and physical fitness is expected to continue expanding. As a result of this, vitamins and dietary supplements (VDS) are expected to show considerable growth.

Major products- Cough, cold and allergy remedies, vitamins and dietary supplements (VDS), analgesics and medicated skin care products.

Major Therapeutic segments-

Cardiovascular- Mexico is dealing with two trends at the same time: a large young population and an ageing population, hence specialty care products are becoming increasingly important as diseases considered exotic in Mexico 7-8 years ago, are becoming a major source of growth for pharma companies.

Cardiovascular, anti-infectives, respiratory, vitamins, digestives, anti-tuberculosis, anti-malarial, anti-diabetic and analgesics,  Isosorbide dinitrate, Verapamil, Diltiazem, Propranolol, Nitroglycerine; Procainamide, Lidocaine, Enalapril, Nifedipine, Furosemide, Minoxidil, Pravastatin, Simvastatin, Chlorthalidone, Spironolactone are some of the cardiovascular drugs used for treatments in Mexico.

Diabetes Market- Diabetes is growing every day in Mexico, and the Ministry of Health has declared it one of the most important health issues. Diabetes is of major concern in Mexico, specifically with reference to Type 2 diabetes when compared to Type 1. Estimated diabetic patients in Mexico are 4.4 million. Prevalence rate of adult population is estimated to be 14.2%.

Tolbutamide, tolazamide, glimipiride, etformin, pioglitazone, rosiglitazone, insulin etc are the popular drugs used in the treatment of Type 2 diabetes.

Document info
Document views65
Page views65
Page last viewedTue Jan 24 07:25:13 UTC 2017